Bexarotene Patent Expiration
Bexarotene is Used for treating cutaneous lesions in patients with refractory or persistent stage IA and IB cutaneous T-cell lymphoma. It was first introduced by Valeant Pharmaceuticals Luxembourg Sarl
Bexarotene Patents
Given below is the list of patents protecting Bexarotene, along with the drug name that holds that patent and the company name owning that drug.
| Drug Used in | Drug Patent Number | Drug Patent Title | Drug Patent Expiry | Drug Owner |
|---|---|---|---|---|
| Targretin | US5962731 | Compounds having selective activity for retinoid X receptors, and means for modulation of processes mediated by retinoid X receptors |
Oct 05, 2016
(Expired) | Bausch |
| Targretin | US5962731 | Compounds having selective activity for retinoid X receptors, and means for modulation of processes mediated by retinoid X receptors |
Oct 05, 2016
(Expired) | Valeant Luxembourg |
| Targretin | US5780676 | Compounds having selective activity for Retinoid X Receptors, and means for modulation of processes mediated by Retinoid X Receptors |
Jul 14, 2015
(Expired) | Bausch |
| Targretin | US5780676 | Compounds having selective activity for Retinoid X Receptors, and means for modulation of processes mediated by Retinoid X Receptors |
Jul 14, 2015
(Expired) | Valeant Luxembourg |
Bexarotene's Family Patents
Explore Our Curated Drug Screens
Bexarotene Generic API Manufacturers
Several generic applications have been filed for Bexarotene. The first generic version for Bexarotene was by Bionpharma Inc and was approved on Aug 12, 2014. And the latest generic version is by Cipla Ltd and was approved on Dec 10, 2024.
Given below is the list of companies who have filed for Bexarotene generic, along with the locations of their manufacturing plants worldwide.
1. AMNEAL
Amneal Pharmaceuticals Llc has filed for 1 generic for Bexarotene. Given below are the details of the strengths of this generic introduced by Amneal.
| Strength | Dosage Form | Availability | Application Pathway | TE code | Launch Date |
|---|---|---|---|---|---|
| 1% | gel | Prescription | TOPICAL | AB | Apr 27, 2022 |
Manufacturing Plant Locations New
Amneal's manufacturing plants are situated in 2 countries - United States, India. Given below are the details of these plant locations as well as the firm names of Amneal as present at those locations.
| Country | City | Firm Name | ||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| United States |
| |||||||||||||||||
| India |
| |||||||||||||||||
2. AMNEAL PHARMS NY
Amneal Pharmaceuticals Of Ny Llc has filed for 1 generic for Bexarotene. Given below are the details of the strengths of this generic introduced by Amneal Pharms Ny.
| Strength | Dosage Form | Availability | Application Pathway | TE code | Launch Date |
|---|---|---|---|---|---|
| 75MG | capsule | Prescription | ORAL | AB | Sep 4, 2018 |
3. ANI PHARMS
Ani Pharmaceuticals Inc has filed for 1 generic for Bexarotene. Given below are the details of the strengths of this generic introduced by Ani Pharms.
| Strength | Dosage Form | Availability | Application Pathway | TE code | Launch Date |
|---|---|---|---|---|---|
| 75MG | capsule | Prescription | ORAL | AB | May 8, 2018 |
4. ASCENT PHARMS INC
Ascent Pharmaceuticals Inc has filed for 1 generic for Bexarotene. Given below are the details of the strengths of this generic introduced by Ascent Pharms Inc.
| Strength | Dosage Form | Availability | Application Pathway | TE code | Launch Date |
|---|---|---|---|---|---|
| 75MG | capsule | Prescription | ORAL | AB | Sep 6, 2024 |
5. BIONPHARMA
Bionpharma Inc has filed for 1 generic for Bexarotene. Given below are the details of the strengths of this generic introduced by Bionpharma.
| Strength | Dosage Form | Availability | Application Pathway | TE code | Launch Date |
|---|---|---|---|---|---|
| 75MG | capsule | Prescription | ORAL | AB | Aug 12, 2014 |
Manufacturing Plant Locations New
Bionpharma's manufacturing plants are situated in 1 country - United States. Given below are the details of these plant locations as well as the firm names of Bionpharma as present at those locations.
| Country | City | Firm Name | ||
|---|---|---|---|---|
| United States |
| |||
6. CIPLA
Cipla Ltd has filed for 1 generic for Bexarotene. Given below are the details of the strengths of this generic introduced by Cipla.
| Strength | Dosage Form | Availability | Application Pathway | TE code | Launch Date |
|---|---|---|---|---|---|
| 75MG | capsule | Discontinued | ORAL | N/A | Dec 10, 2024 |
Manufacturing Plant Locations New
Cipla's manufacturing plants are situated in 1 country - India. Given below are the details of these plant locations as well as the firm names of Cipla as present at those locations.
| Country | City | Firm Name | ||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| India |
| |||||||||||||||
7. HIKMA
Hikma Pharmaceuticals Usa Inc has filed for 1 generic for Bexarotene. Given below are the details of the strengths of this generic introduced by Hikma.
| Strength | Dosage Form | Availability | Application Pathway | TE code | Launch Date |
|---|---|---|---|---|---|
| 75MG | capsule | Prescription | ORAL | AB | Jun 16, 2020 |
Manufacturing Plant Locations New
Hikma's manufacturing plants are situated in 3 countries - United States, Portugal, Jordan. Given below are the details of these plant locations as well as the firm names of Hikma as present at those locations.
| Country | City | Firm Name | ||||||||
|---|---|---|---|---|---|---|---|---|---|---|
| United States |
| |||||||||
| Portugal |
| |||||||||
| Jordan |
| |||||||||
8. TEVA PHARMS USA
Teva Pharmaceuticals Usa has filed for 1 generic for Bexarotene. Given below are the details of the strengths of this generic introduced by Teva Pharms Usa.
| Strength | Dosage Form | Availability | Application Pathway | TE code | Launch Date |
|---|---|---|---|---|---|
| 75MG | capsule | Prescription | ORAL | AB | Jan 14, 2021 |
9. UPSHER SMITH LABS
Upsher Smith Laboratories Llc has filed for 1 generic for Bexarotene. Given below are the details of the strengths of this generic introduced by Upsher Smith Labs.
| Strength | Dosage Form | Availability | Application Pathway | TE code | Launch Date |
|---|---|---|---|---|---|
| 75MG | capsule | Prescription | ORAL | AB | Jul 25, 2018 |